Reports - Pharmacovigilance Market
HealthcarePharmacovigilance Market
Pharmacovigilance Market Size and Projected Growth Through 2035 by Types (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining) by Application (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Pharmacovigilance Market - Segment Analysis
1. Overview
2. Global Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. Global Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. Global Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
5. Global Pharmacovigilance Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Pharmacovigilance Market - Segment Analysis
1. Overview
2. North America Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. North America Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. North America Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
Chapter 5 Europe Pharmacovigilance Market - Segment Analysis
1. Overview
2. Europe Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. Europe Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. Europe Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
Chapter 6 Asia Pacific Pharmacovigilance Market - Segment Analysis
1. Overview
2. Asia Pacific Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. Asia Pacific Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. Asia Pacific Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
Chapter 7 Latin America Pharmacovigilance Market - Segment Analysis
1. Overview
2. Latin America Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. Latin America Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. Latin America Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
Chapter 8 Middle East & Africa Pharmacovigilance Market - Segment Analysis
1. Overview
2. Middle East & Africa Pharmacovigilance Market, 2020 - 2032 (USD Million)
3. Middle East & Africa Pharmacovigilance Market - by Types
3.1. By Spontaneous Reporting
3.2. By Intensified ADR Reporting
3.3. By Targeted Spontaneous Reporting
3.4. By Cohort Event Monitoring
3.5. By EHR Mining
4. Middle East & Africa Pharmacovigilance Market - by Application
4.1. By Pharmaceuticals
4.2. By Biotechnology Companies
4.3. By Medical Device Manufacturers
4.4. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. IQVIA Inc.
2. Cognizant
3. Clinquest Group B.V. (Linical Americas)
4. IBM
5. Laboratory Corporation of America Holdings
6. ArisGlobal
7. Capgemini
8. ITClinical
9. ICON plc.
10. TAKE Solutions Limited
11. Parexel International (MA) Corporation
12. Wipro
13. United BioSource LLC
14. BioClinica Inc. (Clario)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By